Athiras lead clinical candidate, fosgonimeton (formerly ATH-1017 / NDX-1017), is a structurally distinct phosphate prodrug of Dihexa not Dihexa itself
GCH1/BH4/dihydrofolate reductase (DHFR) system The GCH1/BH4/DHFR system is a novel mechanism for suppressing ferroptosis that operates independently of GPX4 [25]
Ensuring battery safety is your responsibility, and you should use the information provided at your own risk
A practical way to view it is as a structure-adding tool inside a program that already includes meal planning, movement, sleep, and stress management
Beyond filling prescriptions, pharmacists play an important role in helping patients understand how to take their medications properly, navigate insurance questions, identify potential side effects, and connect with additional healthcare resources when needed